18th International Myeloma Workshop

September 8 - 11, 2021 - Vienna, Austria

The International Myeloma Workshop is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:

  • Scientific Programs
  • Oral Presentations (on Basic Biology, Preclinical Trials and Clinical Studies)
  • Consensus Panels
  • Poster Presentations
Our sponsors:

COVID-19 Official Statement on the 18th International Myeloma Workshop (IMW)

We are looking forward to the 18th IMW, scheduled to occur in-person from 8-11 September in Vienna, Austria.

The IMS continues to monitor the public health outbreak of the novel coronavirus COVID-19, and the health and safety of IMW attendees is the Society’s top priority. To this end, our professional conference organizer, SPARGO, is developing IMW2021: Meet Safe While Face-to-Face, a full health and safety plan, in close collaboration with the venue, vendors, and outside public health and safety experts. This plan will be posted to the workshop website and updated as circumstances require.

In addition to the face-to-face workshop in Vienna, IMW programming will be livestreamed with remote participation for those unable to travel to Austria. Despite our best efforts to host an entirely in-person IMW, it is difficult to predict the extent of travel restrictions that might remain in place this September.
Whether in-person or virtual, the IMW will present an outstanding scientific program.

Registration and housing reservations for in-person attendees will open in April. Registration for virtual attendees will open this summer.

The IMS would like to thank all of our members, faculty, attendees, and supporters for their understanding during this time. Despite this challenging situation, we are working hard to ensure the 18th IMW is a tremendous success.

Questions can be directed as follows:
General inquires
Registration inquiries
Housing inquiries

Updated April 16, 2021

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events